“breast cancer”的搜索结果，显示 811-820 项，共有 7399 项

1. 妙佑医疗国际 - 乳房自检

   ... 楔形向乳头方向移动。 Share · Tweet; WeChat. WeChat. Close. Weibo. Nov. 26, 2024. 产品与服务. A Book: Beyond Breast Cancer · 书籍：《妙佑医疗国际家庭疗法指南》 ...

2. 血液科- 临床试验- 妙佑医疗国际

   ... cancer treatments for patients with relapsed/refractory multiple myeloma (RRMM). ... breast cancer (up to 6 donors per phenotype: triple negative [HER2 ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   I-SPY TRIAL: Neoadjuvant And Personalized Adaptive Novel Agents To Treat Breast Cancer (I-SPY) ... Cancers With Expansion In Patients With Endometrial Cancer.

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... Breast Cancer. Rochester, Minn. To determine the maximally tolerated dose ... Durvalumab is FDA approved for treatment in lung cancers including non-small cell ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Also eligible are (11) up to 6 donors with triple negative breast cancer and (12) up to 6 donors with colorectal cancer who have no clinical evidence of ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to identify subtype-specific signatures for breast cancer using genomic positioning of plasma DNA fragments, and to validate ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... cancer patients and other female patients whose future fertility will be ... breast cancer (up to 6 donors per phenotype: triple negative [HER2 ...

8. 外科 - 临床试验- 妙佑医疗国际

   Researchers at Mayo Clinic are developing a Biobank of adult stem cell-rich breast organoids, a new research resource to facilitate normal and cancer stem cell ...

9. 复发性乳腺癌- 医生与科室- 妙佑医疗国际

   Connect with others like you for support and answers to your questions in the Breast Cancer support group on Mayo Clinic Connect, a patient community. Breast ...

10. 外科 - 临床试验- 妙佑医疗国际

    Eliminating Breast Cancer Surgery In Exceptional Responders With Neoadjuvant Systemic Therapy. Rochester, Minn. The goal of this clinical research study is ...